Tourmaline Bio's 15min chart shows MACD and KDJ death crosses.

Tourmaline Bio's 15-minute chart exhibited bearish technical indicators, including a MACD Death Cross and KDJ Death Cross at 16:00 on September 24, 2025. This suggests that the stock price may continue to decline, with momentum shifting towards the downside and potentially leading to further decreases in value.

Tourmaline Bio, Inc. (Nasdaq - TRML) experienced a significant shift in its stock price dynamics on September 24, 2025, as indicated by bearish technical indicators on its 15-minute chart. At 16:00, the stock exhibited a MACD Death Cross and KDJ Death Cross, which are commonly used technical analysis tools that suggest a potential reversal in the stock's momentum. These indicators point to a possible downward trend for the company's stock price, with momentum shifting towards the downside.

The MACD (Moving Average Convergence Divergence) Death Cross occurs when the MACD line crosses below the signal line, signaling a potential bearish trend. Similarly, the KDJ (K Moving Average, D Moving Average, J Stochastic Oscillator) Death Cross indicates a bearish reversal when the K line crosses below the D line. Both of these indicators suggest that the stock price may continue to decline, potentially leading to further decreases in value.

Investors should closely monitor Tourmaline Bio's stock price and technical indicators to make informed decisions. It is essential to consider both the technical analysis and any fundamental factors that may impact the company's performance.

For further information on Tourmaline Bio, Inc., visit [Brodsky & Smith's case page]BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: PROS Holdings, Inc. (NYSE – PROS), Paramount Group, Inc. (NYSE – PGRE), Tourmaline Bio, Inc. (Nasdaq - TRML), WideOpenWest, Inc. (NYSE - WOW)^[1].